BSE filing, NSE: IKAB. Summary written from the filing by ALFA Finder's alert engine.
Mkventures Capital Ltd: key numbers
- Share price
- ₹995.95
- Market cap
- ₹382.8 Cr
- Revenue (annual)
- ₹17.93 Cr
- Net profit (annual)
- ₹10.61 Cr
- P/E (TTM)
- 53.1×Sector 19.7×
- Promoter holding
- 74.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mkventures Capital Ltd
All →Mkventures Capital Board Meeting Date
MKVentures Capital will hold a board meeting on November 3, 2026 to consider unaudited half-year results. Agenda items are only proposed at this stage.
Mkventures Capital Other Announcement
Mkventures Capital Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Mkventures Capital Annual General Meeting
MKVentures Capital Limited concluded its 35th Annual General Meeting. Shareholders transacted ordinary and special business, including the adoption of financial statements and director re-appointment.
Mkventures Capital Management Change
Independent Director Ms. Shruti Mimani resigned effective September 28, 2026, due to her relatives' acquisition of approximately 4% of the company's total voting share capital.
Mkventures Capital Other Announcement
Directors' immediate relatives (Ankit Bahety, Sushil Bahety, Padma Bahety, and HUF) acquired a total of 163,544 equity shares of Mkventures Capital Ltd via market purchase.
Mkventures Capital Other Announcement
The company informed shareholders of the web link to access the Notice of the 35th AGM and the Annual Report for FY 2025-26.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.